DILIGENTRESPOND Trademark

Trademark Overview


On Wednesday, April 23, 2025, a trademark application was filed for DILIGENTRESPOND with the United States Patent and Trademark Office. The USPTO has given the DILIGENTRESPOND trademark a serial number of 99151196. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, June 18, 2026. This trademark is owned by Diligent Pharma, Inc.. The DILIGENTRESPOND trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technical consulting in the field of pharmaceutical studies; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing medical and scientific research information in the field of clinical trials; Consulting services in the field of providing online, non-downloadable software and applications; Providing temporary use of on-line non-downloadable software and applications for assisting third parties in selecting technical service providers to manage clinical trials for the testing of drugs, biologics, and medical devices by analyzing audit data, providing access to a database of vendors, including investigational study sites, and a search engine for database content, managing vendors and investigational study site contacts and regulatory compliance qualifications and bids; Providing on-line non-downloadable so...
diligentrespond

General Information


Serial Number99151196
Word MarkDILIGENTRESPOND
Filing DateWednesday, April 23, 2025
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, June 18, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 28, 2025

Trademark Statements


Pseudo MarkDILIGENT RESPOND
Goods and ServicesTechnical consulting in the field of pharmaceutical studies; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing medical and scientific research information in the field of clinical trials; Consulting services in the field of providing online, non-downloadable software and applications; Providing temporary use of on-line non-downloadable software and applications for assisting third parties in selecting technical service providers to manage clinical trials for the testing of drugs, biologics, and medical devices by analyzing audit data, providing access to a database of vendors, including investigational study sites, and a search engine for database content, managing vendors and investigational study site contacts and regulatory compliance qualifications and bids; Providing on-line non-downloadable software for assisting third parties in selecting technical service providers to manage clinical trials for the testing of drugs, biologics, and medical devices by analyzing audit data, providing access to a database of vendors, including investigational study sites, and a search engine for database content, managing vendors and investigational study site contacts and regulatory compliance qualifications and bids; Providing temporary use of on-line non-downloadable software for clinical trial vendor and selection and management

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 23, 2025
Primary Code042
First Use Anywhere DateWednesday, December 31, 2025
First Use In Commerce DateWednesday, December 31, 2025

Trademark Owner History


Party NameDiligent Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08524
US

Party NameDiligent Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08524
US

Trademark Events


Event DateEvent Description
Wednesday, April 23, 2025NEW APPLICATION ENTERED
Wednesday, April 23, 2025APPLICATION FILING RECEIPT MAILED
Friday, August 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 15, 2025ASSIGNED TO EXAMINER
Thursday, September 25, 2025NON-FINAL ACTION WRITTEN
Thursday, September 25, 2025NON-FINAL ACTION E-MAILED
Thursday, September 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 25, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, September 25, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, September 25, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 25, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, September 25, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, October 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 23, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 15, 2026TEAS STATEMENT OF USE RECEIVED
Thursday, January 15, 2026USE AMENDMENT FILED
Wednesday, May 20, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 9, 2026SU - NON-FINAL ACTION - WRITTEN
Tuesday, June 9, 2026NON-FINAL ACTION E-MAILED
Tuesday, June 9, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 16, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 18, 2026ASSIGNED TO LIE
Thursday, June 18, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 18, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 18, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 18, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED